Adrenal Surgery for Synchronously Metastatic Adrenocortical Carcinoma: A Population-Based Analysis.
Wu K, Liu Z, Li X, Lu Y.
World J Surg. 2021 May;45(5):1457-1465. doi: 10.1007/s00268-021-05957-0. Epub 2021 Jan 22.
PMID:33481081
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner.
Warde KM, Smith LJ, Liu L, Stubben CJ, Lohman BK, Willett PW, Ammer JL, Castaneda-Hernandez G, Imodoye SO, Zhang C, Jones KD, Converso-Baran K, Ekiz HA, Barry M, Clay MR, Kiseljak-Vassiliades K, Giordano TJ, Hammer GD, Basham KJ.
Nat Aging. 2023 Jul;3(7):846-865. doi: 10.1038/s43587-023-00420-2. Epub 2023 May 25.
PMID:37231196
Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease.
Libé R, Huillard O.
Cancer Treat Res Commun. 2023;37:100759. doi: 10.1016/j.ctarc.2023.100759. Epub 2023 Sep 8.
PMID:37690343
Favourable prognosis in metastatic adrenal carcinoma: An unexpected outcome.
Hassan I, Sheikh A.
J Pak Med Assoc. 2022 Oct;72(10):2101-2104. doi: 10.47391/JPMA.3494.
PMID:36661007
A review of mitotane in the management of adrenocortical cancer.
Del Rivero J, Else T, Hallanger-Johnson J, Kiseljak-Vassiliades K, Raj N, Reidy-Lagunes D, Srinivas S, Gilbert J, Vaidya A, Aboujaoude E, Bancos I, Tito Fojo A.